{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:25:09Z","timestamp":1789057509697,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Leishmaniasis is a potentially life-threatening protozoan infection that presents with many clinical manifestations, including cutaneous, mucocutaneus and visceral forms. In patients with rheumatoid arthritis (RA), cutaneous leishmaniasis can persist or re-emerge due to treatment-induced immunosuppression. However, it remains unclear whether this severe opportunistic infection is primarily driven by medication-induced immunosuppression or other poorly understood immune-mediated mechanisms that increase susceptibility.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We describe an unusual case of disseminated leishmaniasis in a 50-year-old Italian man from Apulia, diagnosed with RA two years earlier. Following 15 months of unsuccessful immunosuppressive therapies, he developed severe multilineage pancytopenia, moderate hypertransaminasemia, elevated inflammatory markers, monoclonal gammopathy, clinically significant hepatosplenomegaly, and an ulcerated skin lesion. Initial diagnostic efforts excluded common infectious agents, primary hematological disorders, Felty syndrome, and amyloidosis. The non-specific histopathological findings from the pyoderma gangrenosum-like lesion and the transient clinical response to empirical steroids, broad-spectrum antibiotics, and granulocyte colony-stimulating factors further complicated the diagnostic process. The breakthrough came when a liver biopsy, performed to investigate persistent hypertransaminasemia, revealed <jats:italic>Leishmania<\/jats:italic> amastigotes within macrophages. This finding triggered a re-evaluation of the ulcerated skin lesion, and histological analysis confirmed concurrent cutaneous leishmaniasis. Subsequent bone marrow biopsy also identified <jats:italic>Leishmania<\/jats:italic> amastigotes, clinching the diagnosis of disseminated leishmaniasis. A holistic re-assessment of the patient\u2019s clinical presentation, developmental history, and laboratory, radiologic, and pathological data led to the definitive diagnosis. Treatment with standard intravenous amphotericin B resulted in clinical resolution. A follow-up bone marrow biopsy a few weeks later confirmed the infection had been completely eradicated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In patients with rheumatological conditions, the overlapping symptoms of systemic diseases and infections like leishmaniasis can lead to significant diagnostic delays. This case underscores the importance of comprehensive and meticulous diagnostic evaluations in immunosuppressed individuals to prevent potentially fatal outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1599381","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:27:52Z","timestamp":1749101272000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Disseminated leishmaniasis and rheumatoid arthritis: navigating a clinical conundrum"],"prefix":"10.3389","volume":"16","author":[{"given":"Endrit","family":"Shahini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatello","family":"Marziliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Losito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Zappimbulso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fucilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Cozzolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ingravallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Pappagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Iatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Giovanni","family":"Solimando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260022","article-title":"Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia","volume":"16","author":"Endale","year":"2021","journal-title":"PloS One"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244923","article-title":"Seroprevalence and risk factors associated with exposure to Leishmania infantum in dogs, in an endemic Mediterranean region","volume":"16","author":"Rombol\u00e0","year":"2021","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.6.547","article-title":"Liver morphology and function in visceral leishmaniasis (Kala-azar)","volume":"47","author":"El Hag","year":"1994","journal-title":"J Clin Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2012.10-0558","article-title":"Epidemiology of imported cutaneous leishmaniasis at the hospital for tropical diseases, london, United Kingdom: use of polymerase chain reaction to identify the species","volume":"86","author":"Lockwood","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"B6","article-title":"Visceral Leishmaniasis among immunosuppressed patients with rheumatic diseases","volume":"28","author":"Erre","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/reports5020023","article-title":"A challenging case of visceral leishmaniasis","volume":"5","author":"Solimando","year":"2022","journal-title":"Y Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12879-017-2571-x","article-title":"Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy","volume":"17","author":"Darcis","year":"2017","journal-title":"BMC Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.09.012","article-title":"Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate","volume":"13","author":"Venizelos","year":"2009","journal-title":"Int J Infect Dis IJID Off Publ Int Soc Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"bcr1120115199","DOI":"10.1136\/bcr.11.2011.5199","article-title":"Visceral leishmaniasis in immunosuppressed Caucasian patient","volume":"2012","author":"Toqeer","year":"2012","journal-title":"BMJ Case Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2017.16066","article-title":"Visceral Leishmaniasis in a patient with rheumatoid arthritis undergoing treatment with methotrexate: Case report and review of the literature","volume":"4","author":"Trigkidis","year":"2017","journal-title":"Eur J Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2016.07.005","article-title":"Visceral leishmaniasis in a rheumatoid arthritis patient receiving methotrexate","volume":"13","author":"Reina","year":"2017","journal-title":"Reumatol Clin"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2007.235","article-title":"Leishmaniasis in rheumatoid arthritis","volume":"59","author":"Pizzorni","year":"2007","journal-title":"Reumatismo"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2010.01.011","article-title":"Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab","volume":"77","author":"Molt\u00f3","year":"2010","journal-title":"Joint Bone Spine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel235","article-title":"Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab","volume":"45","author":"Bassetti","year":"2006","journal-title":"Rheumatol Oxf Engl"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0633","article-title":"Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis","volume":"89","author":"Balt\u00e0-Cruz","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.2013.198.issue-6","article-title":"Visceral leishmaniasis in a patient taking adalimumab for rheumatoid arthritis","volume":"198","author":"Berry","year":"2013","journal-title":"Med J Aust"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03169.x","article-title":"Relapse of cutaneous leishmaniasis in a patient with an infected subcutaneous rheumatoid nodule","volume":"141","author":"Vardy","year":"1999","journal-title":"Br J Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1544-x","article-title":"Antibodies against cyclic citrullinated peptides in infectious diseases\u2013a systematic review","volume":"29","author":"Lima","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives","volume":"12","author":"R\u00f6nnelid","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2006.12.001","article-title":"Serum markers of rheumatoid arthritis in visceral leishmaniasis: rheumatoid factor and anti-cyclic citrullinated peptide antibody","volume":"28","author":"Atta","year":"2007","journal-title":"J Autoimmun"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12265","article-title":"Anti-citrullinated peptide antibodies in Sudanese patients with Leishmania donovani infection exhibit reactivity not dependent on citrullination","volume":"81","author":"\u00c5hlin","year":"2015","journal-title":"Scand J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jim.2016.02.007","article-title":"General false positive ELISA reactions in visceral leishmaniasis. Implications for the use of enzyme immunoassay analyses in tropical Africa","volume":"431","author":"Elshafie","year":"2016","journal-title":"J Immunol Methods"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin Arthritis Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2013.05.003","article-title":"Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-\u03b1 antagonists","volume":"11","author":"Neumayr","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5070\/D30C96W76K","article-title":"Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab","volume":"18","author":"Romero-Mat\u00e9","year":"2012","journal-title":"Dermatol Online J"},{"key":"B28","article-title":"Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab","volume":"23","author":"Fabre","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0356-5","article-title":"Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept","volume":"26","author":"Bagalas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"B30","article-title":"Anti-tumor necrosis factor-alpha therapy provokes latent leishmaniasis in a patient with rheumatoid arthritis","volume":"39","author":"Franklin","year":"2009","journal-title":"Ann Clin Lab Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.32.2.160","article-title":"A patient with rheumatoid arthritis under methotrexate and etanercept treatment presenting with fever and pancytopenia: an unexpected guest","volume":"32","author":"Patoulias","year":"2021","journal-title":"Mediterr J Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181c8aa33","article-title":"An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab","volume":"16","author":"Kritikos","year":"2010","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1989","article-title":"Abatacept","volume":"5","author":"Moreland","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4213::AID-IMMU4213>3.0.CO;2-C","article-title":"CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection","volume":"28","author":"Saha","year":"1998","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.161.8.4153","article-title":"Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani","volume":"161","author":"Murphy","year":"1998","journal-title":"J Immunol Baltim Md 1950"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp052790","article-title":"Clinical practice. Monoclonal gammopathy of undetermined significance","volume":"355","author":"Blad\u00e9","year":"2006","journal-title":"N Engl J Med"},{"key":"B37","article-title":"Monoclonal gammopathy in human leishmaniasis","volume":"64","author":"Randi","year":"2006","journal-title":"Neth J Med"},{"key":"B38","article-title":"Monoclonal gammopathy after visceral leishmaniasis: just a coincidence","volume":"16","author":"Rombola","year":"2008","journal-title":"Infez Med"},{"key":"B39","article-title":"Monoclonal gammopathy associated with visceral leishmaniasis","volume":"14","author":"Sharma","year":"2010","journal-title":"Braz J Infect Dis Off Publ Braz Soc Infect Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1590\/S0482-50042006000300003","article-title":"Valor diagn\u00f3stico do anticorpo antipept\u00eddeo citrulinado c\u00edclico na artrite reumat\u00f3ide","volume":"46","author":"Silva","year":"2006","journal-title":"Rev Bras Reumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1599381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:27:55Z","timestamp":1749101275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1599381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":40,"alternative-id":["10.3389\/fimmu.2025.1599381"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1599381","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"article-number":"1599381"}}